Thompson Siegel & Walmsley’s Clorox CLX Stock Holding History

Thompson Siegel & Walmsley’s Portfolio CLX Stock Details CLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-67	Closed	-$9K	–	560
2022 Q2	$9K	Hold	67	–	–	﹤0.01%	488
2022 Q1	$9K	Hold	67	–	–	﹤0.01%	552
2021 Q4	$12K	Hold	67	–	–	﹤0.01%	548
2021 Q3	$11K	Hold	67	–	–	﹤0.01%	622
2021 Q2	$12K	Hold	67	–	–	﹤0.01%	639
2021 Q1	$13K	Hold	67	–	–	﹤0.01%	616
2020 Q4	$14K	Hold	67	–	–	﹤0.01%	582
2020 Q3	$14K	Sell	67 -20	-23%	-$4.45K	﹤0.01%	552
2020 Q2	$19K	Hold	87	–	–	﹤0.01%	523
2020 Q1	$15K	Hold	87	–	–	﹤0.01%	502
2019 Q4	$13K	Buy	87 +20	+30%	+$2.99K	﹤0.01%	618
2019 Q3	$10K	Hold	67	–	–	﹤0.01%	638
2019 Q2	$10K	Hold	67	–	–	﹤0.01%	645
2019 Q1	$11K	Hold	67	–	–	﹤0.01%	591
2018 Q4	$10K	Buy	+67	New	+$10.4K	﹤0.01%	639
2016 Q2	–	Sell	-1,800	Closed	-$227K	–	788
2016 Q1	$227K	Buy	1,800 +300	+20%	+$38.1K	﹤0.01%	367
2015 Q4	$190K	Buy	+1,500	New	+$186K	﹤0.01%	373

Other funds holding CLX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Thompson Siegel & Walmsley's CLX Position: Q3 2022 in Review

Thompson Siegel & Walmsley sold out of Clorox (CLX) in Q3 2022, closing a stake of 67 shares — an estimated $9K sold.

Thompson Siegel & Walmsley first reported a position in CLX in Q4 2015 and held it in 17 quarters. The position peaked at $227K in Q1 2016. 1,045 funds tracked by Wall St. Rank hold CLX as of Q3 2022.

Thompson Siegel & Walmsley reported no remaining Clorox position as of Q3 2022 after selling out during the quarter.
Thompson Siegel & Walmsley sold 67 Clorox shares in Q3 2022, an estimated $9K.
Thompson Siegel & Walmsley first reported a position in Clorox in Q4 2015 and held it in 17 quarters.
Thompson Siegel & Walmsley's Clorox position peaked at $227K in Q1 2016.
1,045 funds tracked by Wall St. Rank held Clorox as of Q3 2022.

Based on Thompson Siegel & Walmsley's 13F filing for Q3 2022, filed 25 Oct 2022.